Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 61.00 | |
25 mg | In stock | $ 88.00 | |
50 mg | In stock | $ 116.00 | |
100 mg | In stock | $ 162.00 | |
500 mg | In stock | $ 397.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 71.00 |
Description | Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention. |
Targets&IC50 | FXa:0.561 nM(Ki) |
In vitro | In thrombosis models involving rats and rabbits, Edoxaban demonstrates a dose-dependent inhibition of thrombus formation. Edoxaban (p.o.) elicits effective anti-Xa activity and achieves high plasma drug concentrations in both rats and monkeys. |
In vivo | Edoxaban (0.256 and 0.508 μM) doubles the prothrombin time in human plasma and partially activates the thromboplastin time. |
Synonyms | DU-176b, DU-176b tosylate Monohydrate, Lixiana, Edoxaban |
Molecular Weight | 738.27 |
Formula | C31H40ClN7O8S2 |
CAS No. | 1229194-11-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 93 mg/mL (126 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Edoxaban Tosylate Monohydrate 1229194-11-9 Metabolism Proteases/Proteasome Thrombin Factor Xa DU-176b DU-176b tosylate Monohydrate Fxa inhibit stroke Lixiana Edoxaban DU-176b Tosylate antithrombotic thromboembolic anticoagulant Inhibitor Edoxaban tosylate Edoxaban Tosylate inhibitor